Skip to main content
Clinical Trials/JPRN-UMIN000043716
JPRN-UMIN000043716
Recruiting
未知

A prospective, multicenter, observational study of the effects of SGLT2 inhibitors/ SPPARMalpha combination therapy on liver function in patients with type 2 diabetes and dyslipidemia - PEMA2i

niversity of Miyazaki0 sites50 target enrollmentAugust 1, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
type 2 diabetes and dyslipidemia
Sponsor
niversity of Miyazaki
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 1, 2021
End Date
December 31, 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity of Miyazaki

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Patients with contraindications to SGLT2 inhibitors and/or pemafibrate 2\. Patients receiving SGLT2 inhibitors and/or pemafibrate 3\. Patients who judged unsuitable for this study by the investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials